This is one outlet's own report from Forbes — the article as it was filed.
AIPROPX ReportForbes · 2h ago
3 Undervalued Stocks To Buy Now For September 2026
Summary Three companies are highlighted as potential buys ahead of their September or October earnings reports. To find the best undervalued stocks to buy for September the following criteria was considered: which stocks have beaten consensus financial targets and raised guidance in 2026, trade below sector or historical multiples to sales or earnings, and report their results this coming September or October. Memory chip supplier Micron Technology, contract manufacturer Jabil and healthcare provider are mentioned, though all have key risks to acknowledge. These offer varied investment strategies.
TABLE OF CONTENTS Top Undervalued Stocks To Buy Now In September 2026 Micron, Jabil, and Cigna Market Capitalization, Price/Earnings Ratio and Earnings Per Share 1. Micron Technology (MU) 2. Jabil (JBL) 3. The Cigna Group (CI) After observing what moves stocks for decades, I’ve come to a simple conclusion: stock prices move up when companies report better than expected results and raise their forecasts. Applying this rule leads to three stocks investors may consider when looking for stock to buy ahead of their next earnings reports.
More specifically, I looked for three publicly-traded companies that have beaten consensus financial targets and raised guidance in more than one consecutive 2026 quarter, trade below sector or historical multiples to sales or earnings, and report their results this coming September or October.
Three companies, Micron Technology, Jabil and The Cigna Group, satisfy these criteria. Micron has the strongest competitive position of the three companies. More specifically, the company benefits from being a leading supplier of memory chips – a scarce resource in high demand due to high AI capital expenditures. However, since Micron’s shares have soared in 2026, the company must beat and raise above expectations for the stock to continue rising.
Jabil, which provides contract manufacturing services, is less exposed to the soaring demand resulting from AI capital expenditures. However, the company is expected to raise guidance after reporting its results in September. Meanwhile, Cigna could rise if investors back away from the AI trade and shift capital to so-called defensive stocks likely not to suffer from the bursting of the AI bubble.
Micron is the only major U.S.-based memory chipmaker and one of the "Big Three" DRAM/NAND producers alongside Samsung and SK Hynix. Micron’s products – particularly high bandwidth memory which are optimized to work with Nvidia AI chips – are in such demand that the company cannot supply all its customers – creating an opportunity to raise prices.
Micron is a top choice because of strong contracted demand; a pattern of beating targets and raising guidance; and a relatively low valuation.
Its key risks are the long-term cyclicality of the memory business, the stock’s large increase so far in 2026 and rising capital costs that could pressure free cash flow.
Jabil provides engineering, supply-chain and manufacturing services. Its fastest-growing unit, Intelligent Infrastructure, builds AI data-center hardware. Jabil also serves automotive, healthcare and digital-commerce markets.
Jabil is a top choice because it has a pattern of beating and raising and there is a catalyst to drive up the stock in September; revenue is speeding up due to AI capital expenditures and valuation is reasonable given the growth.
Key risks of JBL include the company’s high dependence on AI, its higher stock price that has limited potential upside and the thin margins in the manufacturing services industry.
The Cigna Group provides health services through two business segments. Its Evernorth Health Services unit competes in the pharmacy benefit management, specialty pharmacy and care services segments. Cigna Healthcare provides medical insurance to U.S. and international customers.
Cigna stock is a top choice because the company consistently beats and rises; its valuation is deeply discounted compared to peers, and cash generation is growing.
The key risks for Cigna stock are negative recent analyst ratings and rising medical costs.
Micron Technology – a momentum stock – and Jabil – fitting the growth at a reasonable price model; are likely to benefit from strong AI capital expenditures. However, for defensive investors seeking to protect against a downturn in the AI trade, Cigna could be a good fit. Analyzing the stock market outlook for the last months of 2026 may also be important for investors to consider.
AIPROPX is an independent multi-source news index — we track, compare, and connect coverage from across the web into one place you won't find anywhere else.
